ArticlePDF AvailableLiterature Review

Abstract and Figures

Allergic and hypersensitivity reactions such as anaphylaxis and asthma exacerbations may occur during air travel. Although the exact incidence of in-flight asthma and allergic emergencies is not known, we have concerns that this subject has not received the attention it warrants. There is a need to provide passengers at risk and airlines with the necessary measures to prevent and manage these emergencies. A review of the epidemiology, management and approaches to prevention of allergic and asthma emergencies during air travel is presented with the goal of increasing awareness about these important, potentially preventable medical events.
Content may be subject to copyright.
R E V I E W Open Access
In-flight allergic emergencies
Mario Sánchez-Borges
, Richard F. Lockey
Ignacio J. Ansotegui
, Yehia El-Gamal
, Stanley Fineman
, Mario Geller
Alexei Gonzalez-Estrada
, Luciana Tanno
, Bernard Y. Thong
and on behalf of the WAO Anaphylaxis Committee
Allergic and hypersensitivity reactions such as anaphylaxis and asthma exacerbations may occur during air travel.
Although the exact incidence of in-flight asthma and allergic emergencies is not known, we have concerns that this
subject has not received the attention it warrants. There is a need to provide passengers at risk and airlines with the
necessary measures to prevent and manage these emergencies. A review of the epidemiology, management and
approaches to prevention of allergic and asthma emergencies during air travel is presented with the goal of increasing
awareness about these important, potentially preventable medical events.
Keywords: Aircraft, Air travel, Allergic reaction, Anaphylaxis, Asthma, Emergency, Flight, Food allergy
About 2.75 billion passengers are transported worldwide
by airlines every year. Many of these people will have
pre-existing long-term conditions including asthma
and/or allergy which put them at risk of an in-flight
medical emergency. In a smaller minority of people,
these conditions may develop for the first time (i.e. inci-
dent cases) while in flight. It is expected that by 2030,
half of all aircraft passengers will be over 50 years of age
[1]. Up to 44,000 in-flight medical emergencies occur
each year [2], and data suggest that about 17% of such
cases are transferred to a hospital, with 4% resulting in
hospitalization or death.
Systemic allergic reactions (SAR) (a serious systemic al-
lergic reaction is defined as anaphylaxis) and asthma exac-
erbations (AE) may occur during air travel. We have
concerns that to date, these have not received sufficient at-
tention from passengers, airlines, and the medical com-
munity. In view of the potentially avoidable morbidity and
mortality, a review about the epidemiology, management
and prevention of allergic and asthma emergencies during
air travel is needed to increase awareness about these re-
actions and how to prevent and treat them. Likewise,
travel for the allergic and asthmatic passenger poses a
number of problems, in particular for those with a history
of a food-induced SAR or who have asthma. Patients may
experience, among other, fear of suffering an allergic
reaction or AE, problems regarding which medications to
carry on board, how to use them, or not receiving appro-
priate attention when seeking support from airline
personnel about their potential needs [3].
The frequency of these reactions among susceptible
passengers is unknown; however, data from peanut aller-
gic individuals indicate that approximately 9% of them
have experienced some sort of allergic reaction during
flights [4, 5].
Medical emergencies during air travel
In-flight medical emergencies occur in 1 per 11,000 pas-
sengers [6] or 1 in every 604 flights [2]. A number of
reasons are proposed to explain the incidence of medical
and allergic events during air travel, and those are sum-
marized in Table 1. The most common in-flight medical
events include syncope, gastrointestinal and cardiac
problems [2, 7, 8].
Alterations in passenger cabin during flight:
implications of physiological changes during air
travel to allergic and hypersensitivity diseases
There are two major concerns about allergic and respira-
tory diseases when traveling by air. The first is related to
the cabin pressure is equivalent to an altitude of 6000 to
* Correspondence:
Allergy and Clinical Immunology Department, Centro Médico Docente La
Trinidad, Caracas, Venezuela
Clínica El Avila, 6a.transversal Urb. Altamira, piso 8, consultorio 803, Caracas
1060, Venezuela
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (, which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
( applies to the data made available in this article, unless otherwise stated.
Sánchez-Borges et al. World Allergy Organization Journal (2017) 10:15
DOI 10.1186/s40413-017-0148-1
8000 ft, exposing passengers to a partial pressure of arterial
oxygen of 60 mm Hg compared to 75 to 100 mm Hg at sea
level. Thus, the partial pressure of oxygen in the cabin air
at cruising altitude is 2530% lower than at sea level. A
slight fall in oxygen blood saturation occurs, ranging from
92 to 95%, followed by compensatory hyperventilation and
tachycardia [9]. These physical alterations may affect pas-
sengers who have cardiac, respiratory or hematologic
(anemia) diseases, theoretically increasing the risk of exac-
erbations of allergic and hypersensitivity reactions such as
These pressure changes can also result in blocked
ears or sinusesor, occasionally, barotitis or barosinusi-
tis. These conditions can usually be prevented by yawn-
ing, chewing gum during the flight, and by using a
sympathomimetic nasal spray such as oxymetazoline be-
fore ascent and descent.
The dry cabin atmosphere (with humidity 618%) can
also irritate the mucosal membranes of the mouth and
upper respiratory tract. Likewise, dehydration can occur,
especially in a passenger taking a diuretic. Therefore,
drinking plenty of extra fluids is recommended during
flight [10].
Asthma and allergic reactions
Allergic reactions account for an estimated 24% of
medical problems on board commercial airliners
(Table 2) [5, 1113]. Buehrle and Gabler observed that
allergywas the 7th most common cause of in-flight
medical problems between 2002 and 2007, ranging from
1.5 to 2.5% [1]. During the same period asthmatic events
were 14th in frequency (0.6 to 3.2%).
Some authors propose that an AE is the most com-
mon, and potentially the most life-threatening condition
reported by major airlines. According to Dowdalls study,
serious allergic reactions rarely occur. Respiratory events
were the 5th cause of aircraft medical conditions,
whereas allergic diseases, including urticaria, angio-
edema, additional forms of acute dermatitis, AE, and
SAR were the 11th most common [6]. SAR in airplanes
are most commonly triggered by foods (peanuts, tree
nuts, and seafood) or medications. Very rarely these are
triggered by insect stings or an insecticide spray [14].
There are reports of passengers having experienced
idiopathic anaphylaxis while in flight, administering self-
injected epinephrine (adrenaline) in the lavatory, and
not notifying the flight attendant (Greenberger P, per-
sonal communication). There are also reports of attacks
that have necessitated plane diversion to the closest
Other publications report that allergic emergencies are
responsible for 2.2% of all medical problems and result
in 4.5% of aircraft diversions [2]. Allergic reactions were
the 7th most frequent cause of medical events, and der-
matologic manifestations, including skin rashes, the 9th
most common cause in Baltszeks study [11].
An article by Nable et al. on in-flight medical emer-
gencies did not discuss allergic conditions or SAR, al-
though it did mention a 12% incidence of respiratory
reactions [8]. This prompted Casale and Lemanske to
submit a letter to The New England Journal of Medicine
highlighting the need to consider anaphylaxisas a re-
action likely to occur during flights [15].
The lack of recognition of allergic reactions as an im-
portant cause of medical events during air travel could
be due to the fact that they are rare, or because they are
under-recognized, or diagnosed and not reported, since
methods to report such reactions are different and not
standardized [16, 17]. This is an area that therefore war-
rants further study. As previously stated, passengers
often do not report medical problems during flight [5].
In-flight treatment of allergic emergencies and
Treating medical emergencies during flight is a major
challenge and air travel is an important concern for sub-
jects with asthma and a history of a SAR.
The resources to treat allergic emergencies are some-
what limited. In the United States, the Federal Aviation
Administration requires the inclusion of epinephrine in
medical kits carried on board [18]. These emergency med-
ical kits typically contain the following medications [19]:
Table 1 Rick factors for medical and allergic events during air
An increase of passengers age
Flight stress and anxiety, including
increased security procedures
Disruption of routine
Changes in the cabin environment
(temperature, humidity, air pressure)
Decreased seat space
Flight delays
Alcohol/drug intake
Longer flights
Altered circadian rhythm
Jet lag
Pre-existing medical conditions
Table 2 Prevalence of in-flight allergic reactions
Authors (year of publication) Prevalence (%) Reference
Szmajer et al. (2001) [13] 2.4 13
Delaune et al. (2003) [12] 2.8 12
Baltsezk (2008) [11] 3.7 11
Sand et al. (2012) [16] 2.2 17
Sánchez-Borges et al. World Allergy Organization Journal (2017) 10:15 Page 2 of 5
Aqueous epinephrine (adrenaline) 1:10000 and
1:1000 dilution.
Albuterol (salbutamol) for nebulization.
Bronchodilator aerosol inhaler.
Cortisol (hydrocortisone).
Antihistamines tablets and injectable (commonly
A recommendation from this World Allergy
Organization (WAO) expert group for in-flight treat-
ment of a SAR and AE is:
a) For AE, inhaled bronchodilator and oxygen.
Consider an oral, intramuscular or intravenous
corticosteroid for moderate to severe symptoms and
intramuscular epinephrine for severe symptoms.
b) For mild, moderate, and severe SAR, intramuscular
epinephrine 0.01 mg/kg up to 0.5 mg of 1:1000
solution IM in the anterior lateral thigh. Repeat as
Food-induced SAR are increasingly being observed in
many parts of the world. Strategies to reduce the risk of
a SAR while traveling should begin during the early
planning of the plane trip. Advice from their treating
physician or allergist/immunologist should be obtained
about preventive measures to be implemented before or
during the flight. Likewise, a treatment plan should be
instituted in case there is an inadvertent contact with a
known allergen, i.e., a peanut [2025].
Greenberger and Lieberman propose that subjects with
idiopathic anaphylaxis not travel within a week of a previ-
ous episode and recommend the administration for an
adult of prednisone 4060 mg and an H1 antihistamine
by mouth each morning for 1 week before travel. This can
help reduce the frequency and severity of episodes [26]. If
the flight is longer than 1 week after an episode of idio-
pathic anaphylaxis, empiric therapy should be initiated
and continued to reduce the likelihood of an attack while
in flight. For example, the passenger can be converted to
alternate day prednisone.
Medical departments of major airlines can also be con-
sulted about specific questions and recommendations for
air flights on individual carriers. Physicians on board
should be contacted immediately by the airline crew
for any emergency, including allergic emergencies, to
determine what treatment should be instituted and if
the plane should be diverted to the nearest airport. In
addition to medical kits on board and special training
of the crew on the management of medical emergen-
cies, airlines may have remote access to medical ser-
vices which can monitor and give instructions for the
Table 3 Measures that reduce the risk of an in-flight reaction to
peanut and tree nuts
1. Passengers requesting any kind of special accommodation
(e.g., peanut/tree nut snacks not be distributed, announcement to not
eat items with peanut/tree nut, request special peanut/tree nut-free
meal, buffer zone, pre-board, request to sit in a certain seat/zone).
2. Peanut/tree nut-free meals.
3. Wiping of tray tables
4. Avoidance of airline pillows or blankets
5. Buffer zones around which peanut or nut products cannot be
6. Request other passengers not to consume peanut/tree nut-containing
7. Announcement that passengers do not eat peanut/tree nut
containing goods
8. Not consuming airline-provided food
Modified from reference [28]
Table 4 Airline policies for allergic passengers (Data from 13 air
Number of airlines
Pre-boarding arrangements
Request a food buffer zone5
No buffer zone3
Request allergen-free meal1
Pre-boarding to wipe down seats
and table trays
Yes 4
No 1
Buffer zone for fragrance sensitivity 2
Announcements to inform customers
there is a peanut or tree-nut allergic
passenger on board or that peanut
products will not be served
Yes 4
No 7
Free snack policy on peanut/nut/sesame
Serving peanuts Yes 2
No 11
Serving nuts and sesameaw Yes 8
No 1
First class warmed nuts 3
Gluten-free meals Yes 11
No 1
Lactose-free meals 1
Shellfish served Yes 4
No 3
Fish served Yes 6
No 1
Buffer zones for passengers allergic to pets 5
In general air lines cannot guarantee an entirely peanut-free environment.
Modified from reference [30]
Sánchez-Borges et al. World Allergy Organization Journal (2017) 10:15 Page 3 of 5
best treatment until the plane arrives at a location
where the passenger can be adequately treated.
Measures to avoid peanut and tree nut exposure for
peanut and tree nut allergic individuals have resulted in
lower odds of in-flight SAR from these foods (Table 3)
[27, 28]. Since these measures may be difficult to imple-
ment, can cause discomfort for some passengers, and re-
sult in higher costs of travel, airlines and some travelers
might be reluctant to implement them.
Airline policies on allergy
Many airline carriers have devised strategies to prevent
SAR and AE during travel (Table 4). However, there are
no standardized measures to do so and each carrier has
its own recommendations. Retrieving first-hand infor-
mation about SAR and AE is difficult [29]. A summary
of proposed airline policies is presented in Table 5 [30].
As greater numbers of people fly, the number of AE and
SAR are likely to increase during flights in the future.
Therefore, passengers at risk should be aware of the ne-
cessary measures to prevent and manage these emergen-
cies. It is also vitally important that airlines are prepared
to deal with these diseases by providing the necessary
strategies to decrease the incidence of SAR and AE. They
also should have the necessary means to treat these reac-
tions when and if they occur. There is a clear opportunity
for airlines to work alongside allergists/immunologists to
implement evidence-based recommendations to prevent
allergic reactions during flight, especially SAR.
AE: Asthma exacerbation; SAR: Systemic allergic reaction; WAO: World Allergy
This is a product of the Anaphylaxis Committee of the World Allergy
Organization. The authors thank the Board of Directors for approval and
support of the paper.
Not applicable.
Availability of data and materials
Not applicable.
MSB drafted the manuscript. All authors contributed to the conception of
the review and revising it critically for important intellectual content. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Consent for publication was granted by all authors.
Ethics approval and consent to participate
Not applicable.
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
Allergy and Clinical Immunology Department, Centro Médico Docente La
Trinidad, Caracas, Venezuela.
Allergy Section, Department of Internal
Medicine, Hospital Universitari Vall dHebron, Barcelona, Spain.
Research Group, Institut de Recerca Vall dHebron, Universitat Autònoma de
Barcelona, Barcelona, Spain.
Allergie-Centrum-Charité, Klinik für
Dermatologie, Venerologie und Allergologie, Campus Charité Mitte,
Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Division of
Allergy and Immunology, Department of Internal Medicine, University of
South Florida Morsani College of Medicine, Tampa, FL, USA.
Allergy and
Respiratory Research Group, Usher Institute of Population Health Sciences
and Informatics, The University of Edinburgh, Edinburgh, UK.
Division of
Allergy-Immunology, Department of Medicine, Northwestern University
Feinberg School of Medicine, Chicago, IL, USA.
Department of Allergy and
Immunology, Hospital Quironsalud Bizkaia, Bizkaia, Spain.
Department of
Allergy, Clinical Research Center for Allergy and Rheumatology, Sagamihara
National Hospital, Kanagawa, Japan.
Pediatric Allergy & Immunology Unit,
Childrens Hospital, Ain Shams University, Cairo, Egypt.
Department of
Pediatric Allergy & Immunology, Emory University School of Medicine,
Atlanta Allergy & Asthma, Atlanta, USA.
Division of Medicine, Academy of
Medicine of Rio de Janeiro, Rio de Janeiro, Brazil.
Division of Allergy and
Clinical Immunology, Department of Medicine, Quillen College of Medicine
and Center for Excellence for Inflammation, Infectious Disease and Immunity,
East Tennessee State University, Johnson City, TN, USA.
Hospital Sírio
Libanês, São Paulo, Brazil.
University Hospital of Montpellier, Montpellier,
and Sorbonne Universités, Paris, France.
Department of Rheumatology,
Allergy and Immunology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng,
Clínica El Avila, 6a.transversal Urb. Altamira, piso 8, consultorio
803, Caracas 1060, Venezuela.
Received: 19 December 2016 Accepted: 23 March 2017
1. Buehrle E, Gabler A. Notfallmedizin in flugzeng: erste hilfe über den wolken.
Dtsch Arztebl. 2005;102:33842.
2. Peterson DC, Martin-Gill C, Guyette FX. Outcomes of medical emergencies
on commercial airline flights. N Engl J Med. 2013;368:207583.
3. Barnett J, Botting N, Gowland MH, Lucas JS. The strategies that peanut and
nut-allergic consumers employ to remain safe when travelling abroad. Clin
Transl Allergy. 2012;2:12.
4. Dowdall N. Is there a doctor on the aircraft?Top 10 in-flight medical
emergencies. Br Med J. 2000;321:13367.
5. Comstock SS, DeMera R, Vega LC, Boren EJ, Deane S, Haapanen LA, Teuber
SS. Allergic reactions to peanuts, tree nuts, and seeds aboard commercial
airliners. Ann Allergy Asthma Immunol. 2008;101:516.
6. Sicherer SH, Furlong TJ, DeSimone J, Sampson HA. Self-reported allergic
reactions to peanut on commercial airliners. J Allergy Clin Immunol. 1999;
Table 5 Recommendations to prevent and manage in-flight
allergic events
Promote the prevention of allergic diseases via passenger education
Medical consultation for high-risk passengers before traveling
Train and re-train aircrews
Promote general preventive measures during the flight: hydration,
food allergen avoidance (especially peanuts, tree nuts, other foods, as
Provide an appropriate place for furry pets away from subjects with
pet allergy
Provide for sufficient quantities of appropriate medications:
epinephrine (adrenaline), β2 agonists for inhalation and nebulization,
oral and injectable corticosteroids and antihistamines
Sánchez-Borges et al. World Allergy Organization Journal (2017) 10:15 Page 4 of 5
7. Sand M, Bechara F-G, Sand D, Mann B. Surgical and medical emergencies
on board European aircraft: A retrospective study of 10189 cases. Crit Care.
8. Nable JV, Tupe CL, Gehle BD, Brady WJ. In-flight medical emergencies
during commercial travel. N Engl J Med. 2015;373:93945.
9. American Medical Association Commission on Emergency Medical Services.
Medical aspects of transportation aboard commercial aircraft. J Am Med
Assoc. 1982;217:100711.
10. Goodwin T. In-flight me dical emer gencies: An overview. Br Med J. 2000;
11. Baltsezk S. Clinic in the air? A retrospective study of medical emergency
calls from a major international airline. J Travel Med. 2008;15:3914.
12. Delaune EF, Lucas RH, Illig P. In-flight medical events and aircraft diversions:
One airlines experience. Aviat Space Environ Med. 2003;74:628.
13. Szmajer M, Rodriguez P, Sauval P, Charetteur MP, Derossi A, Carli P. Medical
Assistance during commercial airline flights: Analysis of 11 years experience
of the Paris Emergency Service (SARIN) between 1989 and 1999.
Resuscitation. 2001;50:14751.
14. Vanden Driessche KSJ, Sow A, Van Gompel A, Vandeurzen K. Anaphylaxis in
an airplane after insecticide spraying. J Travel Med. 2010;17:4279.
15. Casale TB, Lemanske RF. In-flight medical emergencies. N Engl J Med. 2016;
16. Sand M, Morrosch S, Sand D, Altmeyer P, Bechara FG. Medical emergencies
on board commercial airlines: Is documentation as expected? Crit Care.
17. Ruskin KJ. In-flight medical emergencies: Time for a registry? Crit Care.
18. Federal Aviation Administration (FAA), DOT. Emergency Medical Equipment:
Final rule. Fed Regist. 2001;66:1902846.
19. Graf J, Stüben U, Pump S. In-flight medical emergencies. Dtsch Arztebl Int.
20. Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among
children. United States, 19972011. NHCS data brief No. 121. National
Center for Health Statistics.: Hyattsville; 2013.
21. Ansotegui A, Sánchez-Borges M, Cardona V. Current Trends in Prevalence
and Mortality of Anaphylaxis. Curr Treat Options Allergy. 2016 (in press).
22. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T,
Pumphrey R, Boyle RJ. Increase in anaphylaxis-related hospitalizations but
no increase in fatalities: an analysis of United Kingdom national anaphylaxis
data, 19922012. J Allergy Clin Immunol. 2015;135:95663.
23. Nocerino R, Leone L, Cosenza L, Berni Canani R. Increasing rate of
hospitalizations for food-induced anaphylaxis in Italian children: An
analysis of the Italian Ministry of Health database. J Allergy Clin
Immunol. 2015;135:8335.e3.
24. Rudders SA, Arias SA, Camargo Jr CA. Trends in hospitalizations for food-
induced anaphylaxis in US children, 20002009. J Allergy Clin Immunol.
25. Mullin s RJ, Dear KB, Tang ML. Time trends in Australian hospital
anaphylaxis admissions in 19981999 to 20112012. J Allergy Clin
Immunol. 2015;136:36775.
26. Greenberger PA, Lieberman P. Idiopathic anaphylaxis. J Allergy Clin
Immunol Pract. 2014;2:24350.
27. Boyce JA, Assaad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M,
Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C,
Camargo Jr CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy
BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE,
Teach SJ, Yawn BP, Schwaninger JM. Guidelines for the diagnosis and
management of food allergy in the United States: Report of NIAID-
sponsored Expert Panel. J Allergy Clin Immunol. 2010;126:S1S58.
28. Greenhawt M, Macgillivray F, Batty G, Said M, Weiss C. International study of
risk-mitigating factors and in-flight allergic reactions to peanut and tree nut.
J Allergy Clin Immunol Pract. 2013;1:18694.
29. Shehata Y, Sheikh A. In-flight anaphylaxis emergencies: lessons gained from
attempting a questionnaire pilot study. Prim Care Respir J. 2007;16:321.
30. Van Evra J, Bennet P, Wicker A. Allergic Living handy chart on the allergy
policies of 13 major air carriers. Allergic Living magazine. Updated March
airlines/. Accessed 18 Dec 2016.
We accept pre-submission inquiries
Our selector tool helps you to find the most relevant journal
We provide round the clock customer support
Convenient online submission
Thorough peer review
Inclusion in PubMed and all major indexing services
Maximum visibility for your research
Submit your manuscript at
Submit your next manuscript to BioMed Central
and we will help you at every step:
Sánchez-Borges et al. World Allergy Organization Journal (2017) 10:15 Page 5 of 5
... Inúmeros são os ambientes dessas ocorrências e para alguns procedimentos existe, sistemas e ferramentas próprias para o atendimento em saúde. Em 2017, aproximadamente 3 bilhões de pessoas usufruíram, em todo o mundo, do transporte aéreo comercial de passageiros e estima-se que cerca de 44.000 emergências médicas ocorram por ano (SÁNCHES-BORGES et al., 2017). ...
... Os passageiros sendo indivíduos saudáveis, pouco percebem os sintomas da adaptação do corpo humano a redução de pressão e ao ar rarefeito. No caso de passageiros com condições médicas instáveis, estes podem ter algum desconforto durante o deslocamento da aeronave (ALVES; DANZI; GRAYZEL, 2017) (SÁNCHES-BORGES et al., 2017). ...
O livro Saúde Coletiva aborda temas relevantes na área e emerge da experiência acadêmica na disciplina, desenvolvendo a curiosidade e a busca de conhecimento sobre o tema. O livro conta com uma coletânea de textos que abordam histórico da reforma psiquiátrica, transtorno mentais, assistência farmacêutica relacionada ao tratamento da anemia na insuficiência renal crônica, saúde comunitária na busca ativa de sintomáticos respiratórios, caracterização molecular do Escherichia coli, educação em saúde no controle do Aedes aegypti, detecção do pé diabético, risco à saúde de pescadores, prática profissional de enfermagem, tomada de decisão em saúde, melhoria dos serviços em saúde e custos descentralizado com a saúde. A saúde coletiva, ramo da saúde pública, debruça-se sobre as causas das doenças para encontrar meios de planejar e organizar os serviços de saúde. Assim sendo, abordamos nesta obra os aspectos epidemiológicos, da promoção da saúde e da gestão e análise de serviços para nortear políticas públicas em prol da saúde da coletividade.
... Allergic reactions are reported to account for approximately 2-4% of all medical emergencies on commercial airline flights [1]. This number is likely to be higher, since acute asthma attacks are documented as a respiratory problem and not necessarily as a symptom of a severe allergic reaction [2]. ...
... Severe allergic reactions on commercial flights are primarily caused by foods (peanuts, tree nuts, or seafood) and medications [1]. Anaphylactic shock is the most extreme form of allergic reaction. ...
Full-text available
Introduction Allergic reactions are reported to account for approximately 2–4% of all medical emergencies on commercial airline flights. In 2016, the International Air Transport Association (IATA) published recommendations on risk prevention in severe allergies. Methods Using a written questionnaire and an internet search, an investigation was conducted on the extent to which airlines operating in Germany have implemented the IATA recommendations and, e.g., offer peanut/nut allergy sufferers appropriate measures. Results Only 14 of the 104 airlines contacted responded to the written survey. Of 115 airlines, 72 provided information for allergy sufferers on their homepage, but mostly in insufficient detail. No results were found for the search term “allergy” (or “Allergie”) on the websites of 43 airlines. The information on the individual airlines has been summarized in table form. Discussion The information offered by many airlines for passengers with allergies is insufficient. To offer greater guidance, updated information has been formulated in German and English, and its use is recommended.
... The World Allergy Organization expert group for in-flight treatment of a systemic allergic reaction or asthma exacerbation recommends intramuscular administration of epinephrine, at the dose already described [40]. And a recent publication suggests that EAI may prove to be a valuable tool in treating lifethreatening allergic reactions during flight [41]. ...
Full-text available
Purpose of review Anaphylaxis is an acute, systemic, life-threatening allergic reaction, and its choice treatment is epinephrine. Epinephrine may be administered by several routes, but intramuscular is the preferred one because of its fast time of action, as well as easy access. Several devices are commercially available for self-administration, with some differences between them. There are concerns about defects or errors in administration when using autoinjectors. Recent findings The main factors that determine the correct use of an autoinjector are the length of needle, body mass index, use of clothing, type of device, and training of the person applying epinephrine. Comparing different devices not only highlights some differences between them; but it also finds the similarities in their effectiveness and defects. There are areas of opportunity in the design and route of administration that may be addressed in future research. Summary This review focuses on devices for treatment of anaphylaxis like autoinjectors and includes analysis of factors specific to the device, as well as those dependent on the patient and who applies the device. The best device will be the one that is available, together with adequate training of patient/caregiver and health personnel for its correct use.
... However, it can be frustrating and associated with impaired quality of life, including bullying of food-allergic children, fear of anaphylaxis during airline travel, and anxiety over restrictions on exercise. 129,130 In medication-triggered anaphylaxis, avoidance of relevant medications, and use of safe substitutes are mandatory. If indicated, skin testing for penicillin allergy, or other drugs, and graded challenge to rule out immediate hypersensitivity or desensitization in the absence of alternative therapies, can be attempted. ...
Full-text available
Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions. The occurrence of anaphylaxis has increased in recent years, and subsequently, there is a need to continue disseminating knowledge on the diagnosis and management, so every healthcare professional is prepared to deal with such emergencies. The rationale of this updated position document is the need to keep guidance aligned with the current state of the art of knowledge in anaphylaxis management. The World Allergy Organization (WAO) anaphylaxis guidelines were published in 2011, and the current guidance adopts their major indications, incorporating some novel changes. Intramuscular epinephrine (adrenaline) continues to be the first-line treatment for anaphylaxis. Nevertheless, its use remains suboptimal. After an anaphylaxis occurrence, patients should be referred to a specialist to assess the potential cause and to be educated on prevention of recurrences and self-management. The limited availability of epinephrine auto-injectors remains a major problem in many countries, as well as their affordability for some patients.
Food allergy affects an estimated 8% of US children younger than 5 years and up to 10% of adults. The incidence of peanut allergy has quadrupled over the past decade in the US and appears to have increased globally as well. The pathophysiology of food reactions may be immunoglobulin E (IgE)–mediated, non–IgE-mediated, or mixed IgE- and non–IgE-mediated, and can affect the skin, gastrointestinal (GI) tract, respiratory tract, and/or cardiovascular system. Foods are major triggers of anaphylaxis in all ages. Increasing levels of serum food-specific IgE or skin-prick wheal diameters correlate with increasing probabilities of reactions. The double-blind, placebo-controlled food challenge remains the diagnostic gold standard. Food allergen avoidance requires education about reading ingredient labels, avoiding cross-contact, and obtaining safe meals. Managing food-induced anaphylaxis requires education about recognizing symptoms and prompt treatment with epinephrine. Early exposure to food through a disrupted skin barrier leads to allergic sensitization, whereas early oral exposure to peanut generally induces tolerance. Current food prevention strategies emphasize early oral exposure to peanut and egg as well as most other foods within the first year of life. Novel therapies utilize both allergen-specific and allergen-nonspecific approaches, with great potential for effective desensitization. The US Food and Drug Administration (FDA) approved the first immunotherapeutic vaccine for peanut in 2020.
In-flight medical emergencies (IFME) are the acute on-service events involving illness or injury to a passenger with the potential for long-term health compromise. With the continuously rising number of flights available, both domestically and internationally, it is conceivable that the number of IFMEs will similarly continue to rise. Although most of these instances are relatively self-limited, the rare instance of a severe occurrence justifies preparation, both from in-flight staff and healthcare providers traveling on these flights. Given these events' sporadic nature and the variable availability of medical support, all physicians need to understand their in-flight ethical and legal capabilities, the available medical supplies, and the most likely etiologies to manage such situations successfully. Most radiologists rarely utilize the hands-on, clinical skills developed in medical school or internship for emergencies beyond allergic contrast reactions. Therefore, they may not be adept in caring for patients during an IFME. As such, we present a thorough overview and literature review for the radiologist regarding the management of various acute IFMEs, with consideration for ethical and legal precedence and a review of medical equipment available on-board.
Full-text available
The cabin environment has many physiological effects on commercial aircraft passengers and medical providers, and environmental stress factors exist. Therefore, it is important for medical providers to understand the effects of aviation physiology and cabin environment on the human body. It should also be remembered that these physiological changes and environmental stress factors can affect passengers as well as flight crew and also medical equipment. Providing medical assistance during a flight offers a number of unique challenges including lower cabin pressure, tight quarters, crowded conditions, and loud background noise. The purpose of this Korean guideline is to offer an overview on various in-flight emergencies that could be anticipated and to outline treatment priorities.
Full-text available
Opinion Statement It has not been until the last decade that we have gained insight to the global epidemiology of anaphylaxis, due to the methodological difficulties of such studies. Heterogeneity in definitions, severity grading and study designs have hampered compiling robust data which can be consistently analysed and compared. Also, previous International Classification of Diseases coding for anaphylaxis has been suboptimal further hindering epidemiological studies. Under-diagnosis is still a major pitfall in anaphylaxis, despite the efforts of national and international scientific societies to improve education of all health care professionals and implement clinical practice guidelines. Further collaborative projects are needed to overcome this gap. Currently, it seems that worldwide incidence of anaphylaxis and admission rates are increasing both in children and adults, according to recent studies. This may be partly due to an improvement in recognition, but most likely, due to a rise in allergic diseases in general and of food and drug allergy in particular. On the other hand, fatality rates seem to remain stable or to decrease slightly. We optimistically could hypothesize that this is a result of improved management, both acutely and in the long-term, but published data are still scarce. Prevention strategies are needed in order to halt this scaling trend; ongoing education on recognition and treatment will aid to improve anaphylaxis outcomes.
Food allergy is an important public health problem that affects children and adults and may be increasing in prevalence. Despite the risk of severe allergic reactions and even death, there is no current treatment for food allergy: the disease can only be managed by allergen avoidance or treatment of symptoms. The diagnosis and management of food allergy also may vary from one clinical practice setting to another. Finally, because patients frequently confuse nonallergic food reactions, such as food intolerance, with food allergies, there is an unfounded belief among the public that food allergy prevalence is higher than it truly is. In response to these concerns, the National Institute of Allergy and Infectious Diseases, working with 34 professional organizations, federal agencies, and patient advocacy groups, led the development of clinical guidelines for the diagnosis and management of food allergy. These Guidelines are intended for use by a wide variety of health care professionals, including family practice physicians, clinical specialists, and nurse practitioners. The Guidelines include a consensus definition for food allergy, discuss comorbid conditions often associated with food allergy, and focus on both IgE-mediated and non-IgE-mediated reactions to food. Topics addressed include the epidemiology, natural history, diagnosis, and management of food allergy, as well as the management of severe symptoms and anaphylaxis. These Guidelines provide 43 concise clinical recommendations and additional guidance on points of current controversy in patient management. They also identify gaps in the current scientific knowledge to be addressed through future research.
To the Editor: Nable et al. (Sept. 3 issue)(1) did not mention that acute allergic reactions may occur on airplanes, probably triggered by a food, especially peanuts (commonly served on flights), a drug, or in rare cases, an insect bite or sting. Food allergies among children increased by approximately 50% between 1997 and 2011.(2) The first-line treatment for anaphylaxis, a severe and often life-threatening reaction, is prompt administration of epinephrine and a hospital visit.(3),(4) Because the need for treatment is often immediate (especially in persons with hypotension or airway compromise) and death may occur before transfer to a hospital, . . .
To the Editor: Nable et al. (Sept. 3 issue)(1) did not mention that acute allergic reactions may occur on airplanes, probably triggered by a food, especially peanuts (commonly served on flights), a drug, or in rare cases, an insect bite or sting. Food allergies among children increased by approximately 50% between 1997 and 2011.(2) The first-line treatment for anaphylaxis, a severe and often life-threatening reaction, is prompt administration of epinephrine and a hospital visit.(3),(4) Because the need for treatment is often immediate (especially in persons with hypotension or airway compromise) and death may occur before transfer to a hospital, . . .
To the Editor: Nable et al. (Sept. 3 issue)(1) did not mention that acute allergic reactions may occur on airplanes, probably triggered by a food, especially peanuts (commonly served on flights), a drug, or in rare cases, an insect bite or sting. Food allergies among children increased by approximately 50% between 1997 and 2011.(2) The first-line treatment for anaphylaxis, a severe and often life-threatening reaction, is prompt administration of epinephrine and a hospital visit.(3),(4) Because the need for treatment is often immediate (especially in persons with hypotension or airway compromise) and death may occur before transfer to a hospital, . . .
AIR TRANSPORTATION is relatively safe: the death rate during flight for the period 1976 to 1979 was one per 6.4 million revenue passengers, with approximately one flight diversion for medical reasons per 10,000 scheduled flights. However, the incidence of nonfatal medical emergencies is unknown. Transport by air of patients who are not critically ill is expeditious, safe, comfortable, and convenient. Airline travel presents two major problems to the medical profession: (1) What advice should be given to a patient who wishes to travel by air? (2) How should the physician respond to emergencies that arise during a flight on which the physician himself is a passenger, and how are common in-flight emergencies handled? Following is a brief review of the principles of high-altitude flight, the potential effects on medical and surgical conditions, and recommendations for care of problems that occur in flight. AIRCRAFT OPERATIONAL CONSIDERATIONS A modern jet airliner flies
When a medical emergency occurs during a commercial flight, health care providers should be prepared to respond. This review offers guidance on how to respond to the more common emergencies and on roles and liabilities in offering medical assistance aboard an airplane.
Studies from the United Kingdom, the United States, and Australia have reported increased childhood food allergy and anaphylaxis prevalence in the 15 years after 1990. We sought to examine whether childhood food allergy/anaphylaxis prevalence has increased further since 2004-2005. We examined hospital anaphylaxis admission rates between 2005-2006 and 2011-2012 and compared findings with those from 1998-1999 to 2004-2005. Overall population food-related anaphylaxis admission rates (per 10(5) population per year) increased from 4.5 in 2005-2006 to 8.2 in 2011-2012 (a 1.5-fold increase over 7 years). The highest rates occurred in children aged 0 to 4 years (21.7 in 2005-2006 and 30.3 in 2011-2012, a 1.4-fold increase), but the greatest proportionate increase occurred in those aged 5 to 14 years (5.8-12.1/10(5) population/y, respectively, a 2.1-fold increase) compared with those aged 15 to 29 years and 30 years or older (a 1.5- and 1.3-fold increase, respectively). Not only did absolute food-related anaphylaxis admissions increase, but the modeled year-on-year rate of increase in overall food-related anaphylaxis admissions also increased over time from an additional 0.35 per 10(5) population/y in 1998-1999 (all ages) to 0.49 in 2004-2005 and 0.63 in 2011-2012 (P < .001). Food-related anaphylaxis has increased further in all age groups since 2004-2005. Although the major burden falls on those aged 0 to 4 years, there is preliminary evidence for a recent acceleration in incidence rates in those aged 5 to 14 years. This contrasts with the previous decade in which the greatest proportionate increase was in those aged 0 to 4 years. These findings suggest a possible increasing burden of disease among adolescents and adults who carry the highest risk for fatal anaphylaxis. Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.